Terms: = Thyroid cancer AND PER1, O15534, 5187, ENSG00000179094, RIGUI
4 results:
1. "Time" for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment.
Miro C; Docimo A; Barrea L; Verde L; Cernea S; Sojat AS; Marina LV; Docimo G; Colao A; Dentice M; Muscogiuri G
Semin Cancer Biol; 2023 Jun; 91():99-109. PubMed ID: 36893964
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma.
Waguespack SG; Drilon A; Lin JJ; Brose MS; McDermott R; Almubarak M; Bauman J; Casanova M; Krishnamurthy A; Kummar S; Leyvraz S; Oh DY; Park K; Sohal D; Sherman E; Norenberg R; Silvertown JD; Brega N; Hong DS; Cabanillas ME
Eur J Endocrinol; 2022 Apr; 186(6):631-643. PubMed ID: 35333737
[TBL] [Abstract] [Full Text] [Related]
3. Clock genes and cancer development in particular in endocrine tissues.
Angelousi A; Kassi E; Ansari-Nasiri N; Randeva H; Kaltsas G; Chrousos G
Endocr Relat Cancer; 2019 Jun; 26(6):R305-R317. PubMed ID: 30959483
[TBL] [Abstract] [Full Text] [Related]
4. Clock genes alterations and endocrine disorders.
Angelousi A; Kassi E; Nasiri-Ansari N; Weickert MO; Randeva H; Kaltsas G
Eur J Clin Invest; 2018 Jun; 48(6):e12927. PubMed ID: 29577261
[TBL] [Abstract] [Full Text] [Related]
